JAMES HARDIE INDUSTRIES PLC (JHX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

JHX

JHX - JAMES HARDIE INDUSTRIES PLC

FNArena Sector : Building Products & Services
Year End: March
GICS Industry Group : Materials
Debt/EBITDA: 1.08
Index: ASX20 | ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

James Hardie Industries is a global building materials company and the largest global manufacturer of fibre cement products. Founded in 1888 it first listed on the Sydney Stock Exchange in 1951. It is now dual-listed on the Australian and New York Stock Exchanges. Management operates from Chicago, Illinois, USA.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$40.00

24 Mar
2025

-6.800

OPEN

$42.92

-14.53%

HIGH

$42.96

5,090,518

LOW

$39.73

TARGET
$55.857

-3.86 change from previous day

39.6% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
ACF . BKW . BRI . FBR . FBU . JLG . MGH . RWC . SFC . SRG . WGN .
FNARENA'S MARKET CONSENSUS FORECASTS
JHX: 1
Title FY25
Forecast
FY26
Forecast
EPS (cps) 247.7 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 15.3 xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/05 - ex-div 32.66c (franking 0%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx177.0
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx5,987.0 M
Book Value Per Share xxxxxxxxxxxxxxx656.9
Net Operating Cash Flow xxxxxxxxxxxxxxx1,360.8 M
Net Profit Margin xxxxxxxxxxxxxxx12.96 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx29.53 %
Return on Invested Capital xxxxxxxxxxxxxxx17.77 %
Return on Assets xxxxxxxxxxxxxxx10.92 %
Return on Equity xxxxxxxxxxxxxxx29.53 %
Return on Total Capital xxxxxxxxxxxxxxx32.45 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx677.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx42 M
Long Term Debt xxxxxxxxxxxxxxx1,803 M
Total Debt xxxxxxxxxxxxxxx1,846 M
Goodwill - Gross xxxxxxxxxxxxxxx295 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx911 M
Price To Book Value xxxxxxxxxxxxxxx9.38

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx683.4 M
Capex % of Sales xxxxxxxxxxxxxxx11.41 %
Cost of Goods Sold xxxxxxxxxxxxxxx3,571 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx988 M
Research & Development xxxxxxxxxxxxxxx71 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.6

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxxxx xx xxxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

25/03/2025

1

Upgrade to Overweight from Equal-weight

$55.00

37.50%

Morgan Stanley acknowledges the premium paid by James Hardie Industries for AZEK but considers the circa -21% decline in the share price as overdone.

The broker upgrades the stock to Overweight from Equal-weight and notes EPS dilution and share price volatility in the short term.

James Hardie has agreed to acquire AZEK for US$8.75bn with a combination of cash and shares. Management is targeting synergies of US$350m, of which true cost synergies are US$125m, excluding commercial revenue synergies, the analyst explains.

Management highlighted cross-selling opportunities, including 55% of siding contractors also doing decking and around 55% of homeowners completing decking and re-siding at the same time.

Target of $55 retained. Overweight. Industry view is In-Line. The broker's earnings forecasts are unchanged pending the finalisation of the transaction.

FORECAST
Morgan Stanley forecasts a full year FY25 dividend of 0.00 cents and EPS of 226.75 cents.
Morgan Stanley forecasts a full year FY26 dividend of 0.00 cents and EPS of 243.60 cents.

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

xx/xx/xxxx

3

xxxxxxxxx xx xxxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

24/02/2025

1

Buy

$59.45

48.63%

Goldman Sachs notes James Hardie's 3Q24 EBIT declined 12%, but beat its forecasts by 6% on solid North America margin which was 107bps ahead of its forecast.

The quality of the margin beat was the highlight, the broker comments, as it was driven by gross margin, with depreciation higher than expected.

While management talked of a relatively stable outlook, the broker forecasts -4% Remove and Replace (R&R) volume decline in FY26, particularly as larger ticket spend categories (like siding) are underperforming in the current cycle.

The stronger 3Q pushed the broker's FY24 net profit forecast up 1%, while FY26 is largely unchanged. Target price rises marginally to $59.45 from $59.30, and Buy retained.

FORECAST
Goldman Sachs forecasts a full year FY25 dividend of 0.00 cents and EPS of 185.38 cents.
Goldman Sachs forecasts a full year FY26 dividend of 0.00 cents and EPS of 251.26 cents.

JHX STOCK CHART